Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release

Description

The goal of this study is to learn about preventing recurrence of Dupuytren's Contracture. The main question it aims to answer are: • Does targeted radiation therapy decrease recurrence of Dupuytren's contracture after treatment with Collagenase Clostridium Histolyticum? Participants will undergo: * Release of Dupuytren's Contracture after Collagenase Clostridium Histolyticum injection * Daily radiation therapy treatment for 5 days followed by 6-8 week rest period and then another course of 5 days of radiation therapy

Conditions

Dupuytren Contracture

Study Overview

Study Details

Study overview

The goal of this study is to learn about preventing recurrence of Dupuytren's Contracture. The main question it aims to answer are: • Does targeted radiation therapy decrease recurrence of Dupuytren's contracture after treatment with Collagenase Clostridium Histolyticum? Participants will undergo: * Release of Dupuytren's Contracture after Collagenase Clostridium Histolyticum injection * Daily radiation therapy treatment for 5 days followed by 6-8 week rest period and then another course of 5 days of radiation therapy

A Prospective Clinical Trial of Radiation Therapy for Dupuytren's Contracture Following Surgical and Non-Surgical Release

Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release

Condition
Dupuytren Contracture
Intervention / Treatment

-

Contacts and Locations

Lebanon

Dartmouth Hitchcock, Lebanon, New Hampshire, United States, 03766

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 45 or greater with DC
  • * Extension deficit \>10 degrees
  • * Unable to simultaneously place the affected finger and palm flat on a table.
  • * Women included in the study will be post-menopausal or using contraception, and a pregnancy test will be performed as standard of care.
  • * For patients who are having multiple CCH injections, only the first 2 joints on given hand will be included
  • * Unsuccessful non-surgical release (\> N/1 disease)
  • * They develop an open wound during CCH
  • * Breast feeding or pregnancy
  • * A chronic muscular, neurologic, or neuromuscular disorder affecting the hands.
  • * Less than the age of 45
  • * They have previously undergone radiation on the hand in which they plan to get CCH injections
  • * They are pregnant women, impaired adults or prisoners

Ages Eligible for Study

45 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Dartmouth-Hitchcock Medical Center,

Lance Warhold, MD, PRINCIPAL_INVESTIGATOR, Dartmouth Health

Study Record Dates

2032-04